1-8 of 8
Caroline Furness
Close
Sort by
Journal Articles

Specific Cytogenetic Abnormalities at Diagnosis Predict Survival after Hematopoietic Cell Transplant in Poor-Risk Pediatric Acute Myeloid Leukemia: A PDWP/EBMT Study

Akshay Sharma, Jacques-Emmanuel Galimard, Angharad Pryce, Senthil Bhoopalan, Arnaud Dalissier, Jean-Hugues Dalle, Franco Locatelli, Charlotte Jubert, Oana Mirci-Danicar, Vassiliki Kitra-Roussou, Yves Bertrand, Franca Fagioli, Fanny Rialland, Alessandra Biffi, Robert F Wynn, Gerard Michel, Francesco Paolo P Tambaro, Ali Abdallah Ahmari, Abdelghani Tbakhi, Caroline Furness, Miguel Ángel Díaz Pérez, Petr Sedlacek, Ivana Bodova, Maura Faraci, Kanchan Rao, Marie Thérèse Rubio, Brenda Gibson, Neel S. Bhatt, Selim Corbacioglu
Journal: Blood
Blood (2022) 140 (Supplement 1): 1882–1884.
https://doi.org/10.1182/blood-2022-162596
Published: 2022
Journal Articles

The Impact of Pre-Transplant Extramedullary Disease on the Outcome of Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia in Children- on Behalf of PDWP/EBMT

Juliana Silva, Jacques-Emmanuel Galimard, Jean-Hugues Dalle, Franco Locatelli, Hawazen S. Alsaedi, Miguel Angel Diaz, Charlotte Jubert, Yves Bertrand, Giuseppina Simone, Peter Bader, Franca Fagioli, Vassiliki Kitra Roussou, Caroline Furness, Robert Wynn, Birgit Burkhardt, Alessandra Biffi, Marc Bierings, Cristina Díaz de Heredia, Arcangelo Prete, Amos Toren, Katharine Patrick, Wolfgang Holter, Arnaud Dalissier, Kanchan Rao, Selim Corbacioglu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12938–12940.
https://doi.org/10.1182/blood-2022-162484
Published: 2022
Journal Articles

T-Cell Replete Unrelated Cord Blood Transplant Give Superior Outcomes to Other Donor Sources in High Risk and Relapsed/Refractory Paediatric Myeloid Malignancy

Claire Horgan, Khushnuma Mullanfiroze, Archana Rauthan, Katharine Patrick, Naeem Akram Butt, Oana Mirci-Danicar, Olya O'Connor, Caroline Furness, Akshay Deshpande, Sarah Lawson, Valerie Broderick, Pamela Evans, Brenda Gibson, Wing Roberts, Sevasti Galani, Amy A. Kirkwood, Beki James, Kanchan Rao, Persis J. Amrolia, Robert F. Wynn
Journal: Blood
Blood (2022) 140 (Supplement 1): 4889–4891.
https://doi.org/10.1182/blood-2022-165327
Published: 2022
Journal Articles

Systematic Intention to Treat Analysis of Real-World Outcomes in Children and Young Adults Receiving Tisagenlecleucel: From Elegibility through Treatment Failure

Macarena Oporto Espuelas, Saskia Burridge, Denise Bonney, Kelly Watts, Claire Roddie, Maeve A O'Reilly, Geoff Shenton, John A Snowden, Caroline Furness, Katarzyna Aleksandra Aleksandra Jalowiec, Lorna Neill, Katherine Clesham, Emma Nicholson, Anna Castleton, Amit Patel, Caroline Besley, Robert F Wynn, Ajay Vora, David I. Marks, Lindsay George, Ben Uttenthal, Sridhar Chaganti, Michelle Cummins, Persis J Amrolia, Rachael E Hough, Sara Ghorashian
Journal: Blood
Blood (2022) 140 (Supplement 1): 2408–2410.
https://doi.org/10.1182/blood-2022-162863
Published: 2022
Journal Articles

High Molecular Response Rate and Overall Survival with FLT3 Inhibitors As MRD-Guided Salvage Treatment for Molecular Failure in AML

Jad Othman, Nicola Potter, Katya Mokretar, David Taussig, Anjum Khan, Pramila Krishnamurthy, Anne-Louise Latif, Paul Cahalin, James Aries, Mariam Amer, Edward Belsham, Eibhlin Conneally, Charles Craddock, Dominic Culligan, Mike Dennis, Caroline Duncan, Caroline Furness, Paraskevi Gkreka, Katherine Hodgson, Wendy Ingram, Andrew King, Panagiotis Kottaridis, Mary Frances McMullin, Unmesh Mohite, Loretta Ngu, Katharine Patrick, Tom Rider, Wing Roberts, Marianne Tang Severinsen, Neill Storrar, Tom Taylor, Nigel H. Russell, Richard Dillon
Journal: Blood
Blood (2022) 140 (Supplement 1): 2002–2004.
https://doi.org/10.1182/blood-2022-159503
Published: 2022
Journal Articles

Updated Analysis of an Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Luke Coyle, MBBS, FRACP, FRCPA, Nicholas J. Morley, Alessandro Rambaldi, MD, Kylie D. Mason, MBBS, MD FRACP, FRCPA, PhD, Gregor Verhoef, MD PhD, Caroline Furness, Rajendra Desai, Noemi Mergen, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 14–15.
https://doi.org/10.1182/blood-2020-141117
Published: 2020
Journal Articles

Intention to Treat Analysis of Real-World Outcomes Following Tisgenlecleucel Therapy for Pediatric and Young Adult ALL through a National Access Programme

Sara Ghorashian, FRCPath, PhD, Caroline Furness, Michelle Cummins, John A Snowden, BSc (Hons), MBChB, MD FRCP, FRCPath, Maeve A O'Reilly, MBBCHBAO, Claire Roddie, PhD MD, Lorna Neill, Emma Nicholson, Caroline Besley, MBBChir, MRCPath, MRCP, Sridhar Chaganti, MDPhDMRCP,FRCPath, John Gillson, MD, Antonio Pagliuca, MBBS, MA, FRCP, FRCPath, Anna Castleton, FRCPath, Amit Patel, MBBS,PhDFRCPath,MRCP, Peter Clark, MA MDFRCP, Robert Fernley, Robert Wynn, MD, Ajay Vora, MD, David I. Marks, MB, MS, FRACP, PhD FRCPath, Geoff Shenton, Persis J Amrolia, FRCP, FRCPath, PhD, Denise Bonney, Rachael E Hough, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–19.
https://doi.org/10.1182/blood-2020-138438
Published: 2020
Journal Articles

Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Luke Coyle, Nicholas J. Morley, Alessandro Rambaldi, MD, Kylie D. Mason, MBBS, MD FRACP, FRCPA, PhD, Gregor Verhoef, MDPhD, Caroline Furness, Alicia Zhang, A. Scott Jung, Janet L. Franklin
Journal: Blood
Blood (2018) 132 (Supplement 1): 400.
https://doi.org/10.1182/blood-2018-99-112280
Published: 2018